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Abstract
Background: Topography and presence of bio-mimetic coatings are known to improve osseointegration. The objective of
this study was to evaluate the bone regeneration potential of porous and osteogenic coatings.
Methodology: Six-implants [Control (CTR); porous titanium coatings (T1, T2); thickened titanium (Ti) dioxide layer (TiO2);
Amorphous Microporous Silica (AMS) and Bio-active Glass (BAG)] were implanted randomly in tibiae of 20-New Zealand
white rabbits. The animals were sacrificed after 2 or 4 weeks. The samples were analyzed histologically and
histomorphometrically. In the initial bone-free areas (bone regeneration areas (BRAs)), the bone area fraction (BAF) was
evaluated in the whole cavity (500 mm, BAF-500), in the implant vicinity (100 mm, BAF-100) and further away (100–500 mm,
BAF-400) from the implant. Bone-to-implant contact (BIC-BAA) was measured in the areas where the implants were installed
in contact to the host bone (bone adaptation areas (BAAs)) to understand and compare the bone adaptation. Mixed models
were used for statistical analysis.
Principal Findings: After 2 weeks, the differences in BAF-500 for different surfaces were not significant (p.0.05). After 4
weeks, a higher BAF-500 was observed for BAG than CTR. BAF-100 for AMS was higher than BAG and BAF-400 for BAG was
higher than CTR and AMS. For T1 and AMS, the bone regeneration was faster in the 100-mm compared to the 400-mm zone.
BIC-BAA for AMS and BAG was lower after 4 than 2 weeks. After 4 weeks, BIC-BAA for BAG was lower than AMS and CTR.
Conclusions: BAG is highly osteogenic at a distance from the implant. The porous titanium coatings didn’t stimulate bone
regeneration but allowed bone growth into the pores. Although AMS didn’t stimulate higher bone response, it has a
potential of faster bone growth in the vicinity compared to further away from the surface. BIC-BAA data were inconclusive
to understand the bone adaptation.
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Introduction
The concept of osseointegration of titanium (Ti) implants [1] is
well known and well documented. With the help of this
knowledge, an osseous interface can reproducibly be formed and
maintained at the implant surface for its long term use. [2]
Although implant treatments have very high success rates, [3]
compromising conditions such as limited bone healing capacities
(in diabetic patients, smokers) and irradiated or grafted host bone
may lead to implant failure. [4] Moreover, the clinical practice is
shifting from an unloaded healing period to immediate or early
implant loading. [5] As implant stability is crucial for the prognosis
of early or immediately loaded implants, osseointegration should
be established as fast as possible. This makes that not only the
quality, but also the acceleration of the osseointegration process
becomes important. This leads to an increasing interest to find
new possibilities for improving the quality and the speed of
osseointegration, by means of physical and/or chemical modifi-
cation of implant surfaces, use of mechanical loading and implant
design optimization. [6–8]
The rationale behind changing the implant surface properties is
to increase the speed of post-implantation biological events so that
the osseointegration can be achieved at a faster rate. Implant
surfaces that stimulate the recruitment of premature osteogenic
cells, leading to a more efficient peri-implant bone formation may
eventually lead to a faster osseointegration. It is, however, difficult
to predict the cell behavior, even on a surface of well-known
properties. [9] The in vivo situation is more complex and not all
aspects of the in vivo environment are predictable. Nevertheless, the
experimental evidence shows that osteoprogenitor cells have a
higher affinity for particular surface topographies and functional
groups, which stimulate them to form bone. [10,11] It is therefore
desirable to apply modification techniques that can produce rough
and/or functionalized surfaces.
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24186Due to the pioneering efforts of Bra ˚nemark et al., [12] Ti
became a favored material for implants. Ti has a very good
chemical and biological stability owing to the spontaneously
formed dioxide layer (TiO2) at the surface. [13] The thickness of
the TiO2 layer can be grown further by means of a technique
called anodic oxidation. [14] Depending on the experimental
conditions, the properties of this oxide layer can be changed in
terms of chemical composition and its 3D porous structure. These
surface features hold potential to improve bone growth over the
implant surface. [15]
During the last three decades the use of cellular porous
materials with the characteristics of high roughness (in mm range)
and high porosities (above 50%) has come a long way from
research to the clinical level. [16,17] Although there are conflicts
about the optimal range of topographic and bulk properties of the
coatings, [18,19] there is enough evidence that these coatings
improve the mechanical interlocking at the implant-surface/bone
interface due to bone tissue growth into the pores. [20] Similarly,
nano-structured surfaces possess unique properties that alter cell
adhesion either due to the effect of their structure on the cells
directly or indirectly through initial surface protein interactions.
[11] In this regard, meso-porous (2 nm# pore size #50 nm [21])
and micro-porous (2 nm# pore size [21]) materials prepared via
sol-gel method can be used because of their biocompatibility,
tunable structure and the possibility of incorporation of growth
factors. [22] In the group of micro-porous materials, AMS is a sol-
gel based silica material, the pores of which are suitable for
incorporation of bioactive small molecules and their controlled
release. [23–25]
Silica (SiO2) based bio-active glass (BAG) materials [26] are
capable of bone formation at the endosseous implant surface,
avoiding its fibrous encapsulation when applied in the form of a
stable mechanical coating. [27] In a biological environment,
different ionic components are released from such glass matrices.
Released components such as Ca
2+ and PO4
32 are known to
promote osteoconduction by forming a calcium phosphate
layer at the surface. [28] Another advantage is the possibility of
incorporation of osteogenic agents which can improve the quality
and rate of healing at the required place. [29] Thus, from the bone
regeneration point of view, SiO2 based BAG exhibits many
properties which can be exploited for a clinical benefit.
Five different surfaces were chosen and prepared for studying
the tissue response in the in vivo rabbit model. The different surface
roughness, chemical composition and functional groups of the test
surfaces led to varying surface physical and chemical properties.
The following surfaces were tested: 1) two porous, pure Ti coatings
with a rough topography and varying internal pore structures 2) a
Ti surface with a thickened dioxide layer 3) Amorphous
Microporous Silica (AMS) coating and 4) a Bio-active Glass
(BAG) coating. It was hypothesized that these test surfaces improve
peri-implant bone formation and osseointegration compared to
commercially pure Ti (cpTi) at two healing periods of 2 and 4
weeks.
Materials and Methods
Implant design and surface modification
Commercially pure Ti sheets (grade 2, Goodfellow, Hunting-
don, UK) 1 mm in thickness were laser cut into discs (Ø 15.5 mm
for the surface characterization and Ø 4 mm as implants for the in
vivo study). After ultrasonic cleaning in acetone (Acros Organics,
Geel, Belgium) and washing in excess distilled water, the discs were
acid-etched in a solution containing 4 vol % HF (40%, Riedel-de
haen, Belgium) and 20 vol % HNO3 (65%, Chemlab, Zedelgem,
Belgium) at room temperature for 60 s. Finally, the Ti discs were
washed again in excess distilled water and autoclave sterilized in
separate inert containers. The cleaned Ti substrates represented
the control group (CTR). The CTR surfaces were modified by 5
test coatings (T1, T2, TiO2, AMS and BAG).
Porous coatings of pure Ti were manufactured by electropho-
retic deposition (EPD) of Ti hydride (TiH2) powder followed by
dehydrogenation and sintering in vacuum. A first type of porous
Ti coating (T1) was applied as described previously by Braem et al.
[30] TiH2 powder (grade P, Chemetall GmbH, Frankfurt (M),
Germany) suspension in absolute ethanol (analytical grade,
Prolabo, Haasrode, Belgium) was prepared using polyethylenei-
mine (PEI, 50 wt% in water, Sigma, Bornem, Belgium) as a
charger and binder. The suspension was consolidated through
EPD, using a controlled voltage power supply (MCN 1400-50,
FUG, Rosenheim, Germany). The Ti substrate was vertically
placed in the deposition cell and coupled as cathod. Finally, the
samples were dehydrogenated at 650uC and sintered at 850uCb y
resistive heating in vacuum (10
26 mbar). For the second porous Ti
coating (T2), TiH2 powder stabilized emulsion was prepared
similar to the procedure as described by Neirinck et al. for
titanium powder deposition, [31] while using cyclohexane
(Prolabo, Haasrode, Belgium) instead of paraffin oil as the
dispersed phase. After adding a TiH2 suspension (as used for
T1), this emulsion was consolidated through EPD and dehydro-
genated and sintered as indicated. The application of a particle
stabilized emulsion results in an interconnected pore structure
similar to T1, but with additional spherical pores included. The
TiO2 layer on the CTR surface was thickened by anodic oxidation
in 1 M H3PO4 (85%, Riedel-de Haen, Belgium) using a controlled
voltage power supply (MCN 1400-50, FUG, Rosenheim, Ger-
many).
AMS was prepared according to Maier et al. [32] Appropriate
amounts of tetraethoxysilane (TEOS) (98%, Acros Organics, Geel,
Belgium), absolute ethanol (VWR, Haasrode, Belgium) and HCl
(37%, Chemlab, Zedelgem, Belgium) were mixed to obtain a
colloidal sol. The molar ratios of TEOS:ethanol:HCl:H2O were
1:3:1.74:6. A sol was obtained by stirring the mixture for 1 h (250
rpm, Variomag Multipoint 15, Daytona Beach, USA). The sol was
then diluted 5 fold in absolute ethanol. The diluted sol was
immediately spin-coated on CTR surfaces. Spin-coating was
performed using an Erichsen device at 1500 rpm for 60 s. The
coatings were dried at room temperature. Finally, the calcination
was carried out by heating up to 65uC and after 5 h heated further
till the final temperature of 300uC. A heating rate of 0.1uC min
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was maintained throughout the heating procedure. After 5 h at the
final temperature, the coatings were cooled to ambient temper-
ature.
BAG coatings were applied on CTR surfaces that were
previously treated by anodic oxidation as described above. This
was done by dipping the substrates during 120 s in a 5 wt%
absolute ethanol based suspension of melt-derived BAG powder,
with a nominal composition of 50.1 wt% SiO2, 25.2 wt% CaO,
20.1 wt% Na2O & 4.6 wt% P2O5 and an average particle size of
1 mm. The samples were allowed to dry for 24 h and sintered at
800uC by resistive heating in vacuum (10
26 mbar). After sintering,
6 surfaces were submerged in cell culture medium for 24 h to
evaluate pH changes of the medium.
Characterization
Surface topography and bonding strength of the
coatings. Quantitative three-dimensional topographical analysis
was performed by the calculation of average roughness (Sa,
amplitude parameter), texture aspect ratio (Str, spatial parameter)
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analysis was carried out by MountainsMapH Premium software
(Digital Surf sarl, Besancon, France). Three samples were analyzed
per group using a scanning white light interferometer (WLI, Wyko
NT 3300; Veeco Metrology Inc., Tucson, USA), employing a
vertical scanning interferometer technique. A total of four
equidistant locations were measured per disc, which resulted in 12
measurements per group. After roughness evaluation, the same
surfaces were qualitatively analyzed using a field-emission-gun
Scanning Electron Microscope (Feg-SEM, XL 30, Phillips,
Eindhoven, The Netherlands). For understanding bulk
characteristics of the porous metal coatings (T1 & T2) and BAG
coatings, metallographic cross-sections of the coatings were
prepared and examined using SEM. Elemental analysis was also
carried out for BAG cross sections before and after implantation
using SEM with associated energy dispersive X-ray spectroscopy
(SEM-EDS, EDAX). The tensile adhesion bond strength of the
coatings on the Ti substrate was evaluated with an adapted version
of ASTM 1147 using an INSTRON 4467 with a load cell of 30 kN
at a crosshead speed of 2.5 mm/min. [30] Such characterization
was carried out for T1, T2 and BAG surfaces. A specimen assembly
ofa coatedTisubstrate (Ø15.5 mm)and anuncoated counterbody
(titanium rod, Ø 10 mm), glued together with FM 1000 adhesive
film (Cytec, NJ, USA) was subjected to a tensile load perpendicular
to the coating surface.
Ethics Statement
The research protocol was approved by the ethical committee
for laboratory animal research of the Catholic University of
Leuven and was performed according to the Belgian animal
welfare regulations and guidelines. (Approval ID: P122/2008)
Surgical procedure
Twenty 6-month old New Zealand white rabbits with an
average weight of 3.9160.29 kg were used in this study. All rabbits
were kept in quarantine for 4 weeks before the surgery. Surgeries
were performed under aseptic conditions. First, the animals were
pre-medicated with an intramuscular neuroleptic analgesic
(VexylanH, 1 mg/kg, CEVA, Brussels, Belgium) and with an
intramuscular anaesthetic (Ketamine 1000H 15 mg/kg, CEVA,
Brussels, Belgium). During the surgery, anesthesia was maintained
using isoflurane, USP (Halocarbon, River Edge, USA). After
applying local anesthetic (Lignospan, Septodond, Cedex, France)
subcutaneously at the surgical site, a longitudinal incision was
made on the medial side of the proximal tibia and both soft tissues
and periosteum were mobilized. Three cavities were prepared
exclusively in the cortical bone of each proximal tibia diaphysis
using a custom-made rotary instrument and a low-speed hand
piece under copious saline irrigation. This cutting tool was
specially designed to create a circular cavity of 4 mm diameter
containing a smaller inner cavity of 2 mm diameter and a depth of
0.5 mm. The base of the cavity was perforated at the centre with a
0.5 mm drill to ensure standardized blood supply during healing
(Figure 1A). Sterilized implants were placed randomly in two
tibiae. The outer cavity was just deep enough to create a step
where the implants could be positioned. These samples were then
covered with a Ti osteosynthesis plate and fixed on the cortical
bone by means of two Ti osteosynthesis screws (Nobel Biocare,
Goteborg, Sweden). This ensured a stable initial fixation of the
implants during the healing period. Skin and fascial layers were
sutured separately. Post operatively, the animals were medicated
with intramuscular buprenorfin as analgesic (TemgesicH 0.05 mg/
kg body weight, Schering-Plough NV, Brussels, Belgium) and
Figure 1. Representative histological section, retrieved after 4 weeks of healing. (A) Scanned image of the histological section. (B) The
same image after being digitally processed for histomorphometrical analyses. Four well-defined areas of interest are delimitated: The bone
regeneration area (BRA) divided into 100 and 400 mm zones for the measurement of bone area fraction parameters (BAF-100 and BAF-400
respectively) and two reference areas (RA’s) positioned in non-affected cortical bone, at each side of the double-stepped cavity. Additionally, two
bone adaptation areas (BAA’s), on each side of the BRA were used to measure bone-to-implant contact (BIC-BAA).
doi:10.1371/journal.pone.0024186.g001
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IU daily (Kela NV, Hoogstraten, Belgium). Each animal received
all experimental and control implants. The surgical site was
allowed to heal for 2 and 4 weeks in 10 rabbits for each healing
period. After the healing periods, the animals were sacrificed with
a 0.1 ml/kg body weight intravenous injection of an embutramide-
mebenzoniumjodide-tetracaine HCl solution (T61H, Intervet,
Mechelen, Belgium).
The double-stepped cavity allowed the identification of two well-
defined areas of interest (Figure 1A, 1B) in the histological section.
The bone regeneration area (BRA) coincided with the limits of the
inner cavity and thus represented a region without pre-existing
bone-to-implant contact (BIC) with a width of 2 mm. Secondly, the
area located at the periphery of the implant disc was named bone
adaptation area (BAA) and represented a region of initial direct
contact between bone and implant. Two reference areas (RA’s)
were determined (Figure 1B) aside each bone adaptation area and
outside the disc area to calibrate the bone’s natural degree of
porosity. The role of these RA’s was to provide information on the
bone fraction of the bone which was not affected by the trauma
caused by the surgery. By considering the bone area fraction (BAF)
of RA’s for the final measurement of the bone area fraction
parameters for bone regeneration analysis, it was ensured that the
inherent variability in bone density of different animals and even
distinct areas of cortical bone were taken into account.
Histological and histomorphometrical analysis
To evaluate the tissue growth into the inner cavity and the bone
response around the implant surface, the specimens were prepared
for histological analysis. Ti discs and surrounding tissues were
gathered en bloc, fixed in a CaCO3 buffered formalin solution for 3
days and dehydrated in an ascending series of ethanol concentra-
tions over 15 days. Embedding was performed by infiltration and
polymerization of methylmetacrylate solution containing 0.018%
benzoylperoxide as catalyst over 14 days. Samples were then
sectioned transversely perpendicular to the implant using a
diamond saw (Leica SP 1600, Leica Microsystems, Nussloch,
Germany). The most central section of each implant was reduced to
a final thickness of approximately 30 mm using a micro-grinding
system (Exakt 400 CS, Exakt, Norderstedt, Germany). The sections
were stained with a combination of Stevenel’s blue and Von
Gieson’s picrofuchsin. Histological examinations were performed
using a light microscope (Laborlux, Leica, Wetzlar, Germany) at a
magnification of 406, 1006and 4006. Images were captured using
a high sensitivity color video camera (JVC TK-1280E, Ibaraki-ken,
Japan) mounted on the light microscope and the assessments of the
histomorphometrical proportions were performed using a commer-
cially available image analysis software (Axiovision 4.0, Zeiss,
Gottingen, Germany) and a customized script particularly pro-
grammed for the needs of the semi-automatic analysis.
All areas of interest mentioned in this study were semi-
automatically demarcated in a reproducible manner using
customized scripts made and ran in the image analysis software.
Finally, the following variables were recorded for each histological
section: The Bone area fraction (BAF-500, BAF-100 and BAF-
400, in %) was calculated as the percentage of the BRA occupied
by bone trabeculae (BT) proportional to the bone fraction of the
reference areas (RA1 and RA2). The BAF of the whole cavity area
was designated as BAF-500. The BAF measurement in the area
within 100 mm from the implant was indicated as BAF-100. BAF-
400 on the other hand, refers to the BAF measurement in the
region of 100 to 500 mm away from the implant. (Figure 1B) The
BAF’s were calculated according to the following formulas:
. BAF{500~
X
BTBRA{500=BRA{500
  
=
n
X
BTRA1z
X
BTRA2
  
=
h
RA1zRA2 ð Þ g|100;
. BAF{100~
X
BTBRA{100=BRA{100
  
=
n
X
BTRA1z
X
BTRA2
  
=
h
RA1zRA2 ð Þ g|100;and
. BAF{400~
X
BTBRA{400=BRA{400
  
=
n
X
BTRA1z
X
BTRA2
  
=
h
RA1zRA2 ð Þ g|100:
The bone-to-implant contact ratio in the BAA (BIC-BAA,
in %) was calculated by the sum of the regions where bone was in
direct contact to the implant (BIC) in proportion to the total length
(L) of the Ti surface under analysis.
. BIC{BAA~
X
BICBAA1z
X
BICBAA2
  
=
h
LBAA1zLBAA2 ðÞ   |100
Statistical analyses
The statistical analyses were carried out using the SAS 9.2
software package (SAS Institute Inc.). A mixed model was used
since it takes into account the clustered nature of the data. As fixed
effects, we have the implant and the interaction between the
implant and the healing time. Since, all implants of each group
were placed in the same rabbit; the animal was used as a random
effect. Diagnostic plots were used to check normality and
homogenity of the residuals of the model. By using SAS’ estimate
option of proc mixed, the differences between the measurements
of the implants at each healing period were calculated and the
evolution over time (going from 2 to 4 weeks) of the measurements
for each implant. By using the corresponding p-value, the
differences were considered as significant when the 0.05 threshold
was exceeded. Parameters BAF-100 and BAF-400 were statisti-
cally compared. For further analysis, the difference in BAF in the
area close (BAF-100) vs. further away (BAF-400) from the implant
was found out and the change of these differences between BAF-
100 and BAF-400 over time (going from 2 to 4 weeks) indicate the
speed with which the BAF is changing in the respective areas. For
the roughness comparison of the test and the CTR groups, normal
distribution of the obtained data and the homogeneity of the
variances were checked and an unpaired student’s t-test was used
to identify statistical differences among the different treatments in
each group of surfaces at a significance level of 2%.
Results
Surface topography and bonding strength of the
coatings
Compared to the CTR surface (Figure 2A), the qualitative
surface analysis by SEM indicated that the porous coatings T1, T2
and BAG (Figure 2B, 2C, 2D) coatings gave rise to a rough
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observed for the TiO2 and AMS surfaces (Figure 2E, 2F). The
cross-sectional view of the porous Ti coatings, T1 and T2 displays
a very well connected porous structure which differs only in the
presence of additional spherical holes of ca. 50 mm in case of T2.
(Figure 2G, 2H) The approximate thicknesses of T1, T2 and BAG
coating were 87 mm, 183 mm and 10 mm respectively as indicated
by cross-sectional SEM images. (Figure 2G, 2H, Figure 3A) The
BAG coatings almost retain their thickness after 2 and 4 weeks of
implantation. (Figure 3A, 3B, 3C) But the images also indicate
dissolution of the coating after the healing periods. The single
point EDS analysis (Figure 3D, 3E, 3F) indicates presence of Ca
and P in the BAG coating even after 4 weeks of implantation. The
pH of the medium in which the BAG surfaces were submerged for
24 h was 8.260.04. The changes in the Sa value after the
application of T1, T2 and BAG coatings were observed when
compared to the CTR surface (P,0.02). (Table 1) T1 and T2 also
differed mutually in their Sa values (P,0.02). The TiO2 surface
had a similar Sa value as the CTR surface (P.0.02). Even though
the qualitative analysis by SEM indicate no change in the surface
morphology due to application of AMS coating, (Figure 2F) the
roughness (Table 1) was slightly increased (P,0.02). The Str values
for T1, T2 and BAG surfaces (Table 1) were close to 1 while for
AMS was close to 0. For CTR and TiO2 the Str values were close
to 0.5. The change in the surface area as measured by Sdr (Table 1)
was higher (P,0.02) for T1, T2, AMS and BAG compared to
CTR and TiO2. The average bonding strength for the coatings
T1, T2 and BAG was 47.566.1 MPa [30], 28.867.2 MPa and
27.462.8 MPa respectively.
Histological findings
For both healing periods, newly formed tissue comprised of
bone marrow, bone trabeculae and connective soft tissue could be
observed in the regeneration area (Figure 1A). More bone
formation after 4-week healing period was observed compared
to 2 weeks which was also confirmed by the histomorphometrical
analyses. Careful observation of the histological sections showed
no signs of inflammatory response and infection. After 2 weeks of
healing, blood vessels, non-organized osteoblast like cells and
adipocytes could be observed in the regeneration area. (Figure 4A,
4B) Osteoid (Figure 4C) could be detected after both healing
periods but its presence was more pronounced after 2 weeks than
after 4 weeks of healing. Osteoblasts were lined up along the edges
of the osteoid and mineralized bone (MB) indicating very active
bone formation (Figure 4C, 4D). Bone resorption (Figure 4E) at
the implant/bone interface in the BAA region could be observed
at both healing periods though more pronounced after 4 weeks
especially for AMS and BAG surfaces. Light microscope images of
the histological sections after 2 and 4 weeks indicate presence of
bone tissue in the pores of both T1 and T2 coatings. An example
of bone growth in the pores of a T2 coating after 2 weeks of
healing is shown in figure 5.
Histomorphometrical findings
BAF-500 results are graphically represented in figure 6. A
statistically significant difference (P,0.05) was observed for all the
groups when 2- and 4-week results were compared. In the 4-week
group, a statistically significant difference (P,0.05) could be
observed for the BAG surface (61.863.2%) when compared to the
CTR (49.066.3%). No differences were observed for other
groups. After 2 weeks, all surfaces indicate significant differences
when BAF-100 and BAF-400 were compared. (Figure 7A, 7B)
After 4 weeks BAF-400 was higher than BAF-100 only for BAG.
(Figure 7A, 7B) For the BAF parameters, no significant differences
could be observed among the test groups and the CTR in the 2-
week healing period. After 4 weeks, BAF-100 for AMS
(55.264.2%) was significantly higher (P,0.05) compared to
BAG (34.966.2%) and BAF-400 for BAG (67.963.7%) was
higher (P,0.05) than the CTR (49.866.9%) and AMS
(52.366.3%). For T1 and AMS, the change in the differences in
BAF-100 and BAF-400 at 4 and 2 weeks indicate faster bone
regeneration in the area close (100-mm zone) to the implant
compared to the area away (400-mm zone) from the implant. The
results of bone-to-implant contact in the bone adaptation area
(BIC-BAA) are shown in figure 8. A statistically significant
difference can be observed for AMS and BAG when the results
of the 2- and 4-week were compared. After 4 weeks, BAG results
were significantly lower than AMS and the CTR group. For the
implant groups T1, T2, TiO2 and AMS no difference was
observed when compared to the CTR for both healing periods.
Discussion
For bone regeneration applications, the surface of the bulk
material is an important entity, as any foreign material interacts
with its biological environment through its surface. In literature,
different modification paths were used by various researchers to
alter the surface properties of the implants for the desired
Figure 2. SEM images for experimental and control implants. (A) CTR, (B) T1, (C) T2, (D) BAG, (E) TiO2 and (F) AMS. Images (G) and (H)
represent the cross-sectional views of the thick porous Ti coatings T1 and T2 (as shown by figure (B) and (C)) respectively.
doi:10.1371/journal.pone.0024186.g002
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implants, [33] surface topography adjustments and functionaliza-
tion are important strategies. Surface topographies (mm, mm&n m
scale) and their combination have shown to improve cell adhesion
and differentiation in the osteogenic lineage. [10,34,35] Owing to
the high surface area, such surfaces also boost the primary stability
Figure 3. SEM images for BAG coatings in cross-sectional view. (A) before implantation, (B) after 2 weeks and (C) after 4 weeks of
implantation. Images (D), (E) and (F) indicate the corresponding single point EDS analysis.
doi:10.1371/journal.pone.0024186.g003
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implant/bone interface. [10,11] Porous Ti coatings (T1 & T2),
AMS and BAG surfaces used in this work fall into the category of
rough surfaces.
The porous and rough surface coatings (T1 and T2) did not
show any improvement in the bone regeneration quality when
compared to the CTR (Figure 6). As mentioned earlier, the surface
morphology of T1 and T2 resembles that of other metal porous
coatings. [16,17] But the lack of consistency in the properties of
such porous coatings and their corresponding results make it
difficult to understand the influential property of porous metal
surfaces for bone regeneration. [18,19,36-38] The three dimen-
sional structure of the T1 and T2 coatings differ in their internal
structure. The average pore size and porosity for T1 is 20 mm and
50% respectively. The respective values for T2 are 50 mm and
65%. The porosity and the cross-sectional views of T1 and T2
Table 1. Surface analysis results.
CTR TiO2 T1 T2 AMS BAG
Sa [mm] 0.2960.02 0.3160.03 7.8660.73 9.0660.71 0.6160.04 3.2560.44
Str 0.5460.08 0.5360.16 0.7060.10 0.7260.11 0.3260.20 0.7960.08
Sdr [%] 0.3560.04 0.3760.03 102.50621.70 188.98623.60 0.9160.12 97.23626.09
Sa - arithmetic mean of the absolute values of the surface departures from the mean plane.
Str - measure of spatial isotropy or directionality of the surface texture.
Sdr - percentage of additional surface area due to the surface modification as compared to same size of the measurement region of an ideal plane.
doi:10.1371/journal.pone.0024186.t001
Figure 4. Histological analyses of the stained sections. A, B, C and D show representative aspects of bone formation inside bone regeneration
areas (BRAs). (A), (B) BRA filled with non-organized soft tissue, a dense concentration of blood cells and adipocytes (filled red arrows) after 2-weeks.
(C) Osteoid with osteoblast lining (black triangles) depicting a very active bone regeneration process, observed after both healing periods. (D) Later
stage of bone formation (4 weeks) with a well-organized tissue including the presence of trabecular mineralized bone (MB) connected to osteoid. (E)
Partial bone/implant interface in the bone adaptation area (BAA), including part of the BRA. Bone remodeling is visible at the interface (arrow).
doi:10.1371/journal.pone.0024186.g004
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in the bulk of the coating. It was hypothesized that the bone tissue
will respond differently to these differences in the internal structure
of the porous coatings which may lead to possible differences in
cell delivery and mass transport required for bone regeneration to
the bulk of the coating thereby leading to the bone/implant
interlocking. [20] Although the histomorphometrical analysis
indicates no differences in the bone regeneration capacity of the
two surfaces (Figure 6), these porous structures support cell
transport and bone regeneration inside the pores (Figure 5). It is
interesting to observe the newly formed mineralized bone tissue
was formed deep into the coating. This also reveals the
interconnectivity of the pores throughout the coating.
Silica surfaces produced by the sol-gel method can improve cell
adhesion and are therefore capable of faster osseointegration. [26]
Such surfaces are characterized by the surface nano structure and
functionalization can be imparted to these surfaces for biomedical
applications. [39–41] In an attempt to produce a thin SiO2 coating
similar to mesoporous SiO2 materials, AMS was applied to
implant surfaces to study its bone stimulating potential. The
application of a thin AMS coating prepared by sol-gel method
slightly changed the roughness, texture aspect ratio and interfacial
area ratio of the CTR surface. But these changes in the surface
properties did not affect the bone regeneration capacity of AMS
compared to CTR (Figure 6). The faster increase of bone in the
vicinity of the implant (BAF-100) compared to further away (BAF-
400) after 4 weeks of healing, indicate a positive effect of the AMS
surface on bone growth close to the implant.
The bone regeneration potential of BAG surfaces is due to its
degradation ionic products. [27] Comparing BAF-100 and BAF-
400 (Figure 7A, 7B) after 4 weeks, BAG does not show an
osteogenic effect near the implant surface. However, BAG-like
surfaces are known to promote osteoconduction by apatite
formation due to release of ionic components such as Ca
2+ and
PO4
32. [26] But the release of cations (Ca
2+ and Na
+) in the
physiological situation also increases the pH of its surrounding,
along with the induction of bone formation. [26,42] It is known
that the osteoblasts prefer slightly increased pH (7.8) for
proliferation [43,44] but drastic changes in the surrounding pH
can inhibit osteoblast activity and cause cell necrosis and
apoptosis. [43] The in vitro experiment to find out the changes in
Figure 5. Bone growth into the pores of T2 coating after 4 weeks of healing. A similar phenomenon was observed for T1 surfaces after both
the healing periods. The cells and the mineralized bone can be seen deep into the coating (up to the Ti substrate).
doi:10.1371/journal.pone.0024186.g005
Figure 6. Bone area fraction (BAF) comparison for the whole
cavity. The results are the mean values (bars) with standard errors of
the mean after 2 and 4 weeks of healing. BAF was measured for the
whole cavity (BAF-500). The horizontal line indicates a statistically
significant difference (P,0.05). Significant differences for all groups are
not shown for the comparison between 2 and 4 weeks.
doi:10.1371/journal.pone.0024186.g006
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in the pH beyond 8. Moreover, the degradation mechanism of
BAG in the in vivo environment can be more severe compared to
the in vitro tests carried out in this study because of the more active
biological environment and the limited space for the degradation
products. This increased accumulation of degradation products is
likely to additional increase in the pH. As the BAG surface was not
pre-treated for apatite-like structure formation before implanta-
tion, [45] the sudden increase in the alkalinity caused by the
release of cations might have inhibited the osteoblast proliferation
on the implant surface. But the more pronounced bone formation
in the area away from the implant surface (400-mm zone)
compared to the area in the implant vicinity (100-mm zone)
indicates the osteogenic effect of BAG. The presence of the BAG
coating (Figure 3C) on the Ti surface even after 4 weeks of healing
suggests that the bone regeneration effect indeed was due to the
coating. The exact mechanism which prevented bone growth on
the BAG surface is unraveled in this study and therefore needs
further investigation. BAG coating was made on a thickened TiO2
layer for better adhesion of the coating. Similar bone regeneration
by CTR and TiO2 surfaces indicate no adverse effect of the
thickened TiO2 layer on osteogenesis.
Thepresenceoforthopedicandoralimplantsinclosecontactwith
the host tissues increases the rate of bone remodeling which is
strongly dominated by osteoclast activity during the early stages of
healing. [46] The faster inception of biological integration of the
implants by earlier and faster bone regeneration is desirable to avoid
the possible instability of the implant due to bone remodeling.
Ideally, bone formation should take place to the same extent as the
interfacial bone resorption in order to optimize the changeover from
the primary mechanical stability to the secondary biological stability,
thereby ensuring sufficient bone-to-implant contact at all times
during thehealing processand thereafter.Thiswould limit theriskof
interfacial micro-motion in case of early loaded implants. After
implant insertion, the bone undergoes remodeling which continues
at least until 4 weeks. [47] The observed reduction in the BIC-BAA
valuesforAMSandBAGoveraperiodof4weeks(Figure8)suggests
an increased bone resorption. The lower BIC-BAA for BAG
compared toAMS suggests thehigher boneresorption by the former
surface. As a high remodeling activity was observed even after 4
weeks of healing, this study cannot conclude on the eventual effect of
BAG on implant osseointegration. Longer healing observations are
required for complete comprehension.
In summary, application of BAG on an implant surface showed a
superior bone regeneration capacity in the cavity suggesting its
osteogenic potential. Despite better results in terms of bone
regeneration, BAG does not support osteoconduction. Further
modification of the BAG surface properties is desirable for better
and complete osseointegration of the implants. To achieve the desired
effects,controlledreleaseofBAGionicproductsanddissolutionofthe
coating should be taken into consideration. The later is important for
avoiding excess inflammatory reaction which may cause callus
formation.FurthermodificationofbiocompatibleT1andT2surfaces
isnecessarytoovercometheirlimited boneresponse results(similarto
the CTR) despite having good surface topographic properties. Even
though AMSfellshort to improvethe bone response, it did not hinder
Figure 7. Bone area fraction (BAF) comparison for the 100- and 400-mm zones. The results are the mean values (bars) with standard errors
of the mean. The horizontal lines indicate statistically significant difference. (P,0.05) The * and { indicate differences between the two parameters
BAF-100 and BAF-400 (P,0.05) for the same implant and healing period. Significant differences for the comparison of 2- and 4-week results are not
indicated.
doi:10.1371/journal.pone.0024186.g007
Figure 8. Bone-to-implant contact comparison in the bone
adaptation area (BIC-BAA). The results are the mean values (bars)
with standard errors of the mean. The horizontal lines indicate
statistically significant difference. (P,0.05).
doi:10.1371/journal.pone.0024186.g008
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possibility to use AMS in combination with other porous metal
coatings and as a delivery system for drug molecules [48] and
implantable biomaterial containing tissue inducing substances [49]
need to be explored similar to other zeolite surfaces.
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